English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The subunit ε of bacterial F1 FO ATP synthases plays an important regulatory role in coupling and catalysis via conformational transitions of its C-terminal domain. Here we present the first low-resolution solution structure of ε ofMycobacterium tuberculosis (Mt ε) F1 FO ATP synthase and the nuclear magnetic resonance (NMR) structure of its C-terminal segment (Mt ε103–120 ).Mt ε is significantly shorter (61.6 Å) than forms of the subunit in other bacteria, reflecting a shorter C-terminal sequence, proposed to be important in coupling processes via the catalytic β subunit. The C-terminal segment displays an α-helical structure and a highly positive surface charge due to the presence of arginine residues. Using NMR spectroscopy, fluorescence spectroscopy, and mutagenesis, we demonstrate that the new tuberculosis (TB) drug candidate TMC207, proposed to bind to the proton translocatingc -ring, also binds toMt ε. A model for the interaction of TMC207 with both ε and thec -ring is presented, suggesting that TMC207 forms a wedge between the two rotating subunits by interacting with the residues W15 and F50 of ε and thec -ring, respectively. T19 and R37 of ε provide the necessary polar interactions with the drug molecule. This new model of the mechanism of TMC207 provides the basis for the design of new drugs targeting the F1 FO ATP synthase inM. tuberculosis .

antimicrobial agents and chemotherapy

Variations of Subunit ε of the Mycobacterium tuberculosis F <sub>1</sub> F <sub>o</sub> ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207

Variations of Subunit ε of the Mycobacterium tuberculosis F 1 F o ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207

Variations of Subunit ε of the Mycobacterium tuberculosis F ₁ F _o ATP Synthase and a Novel Model for Mechanism of Action of the Tuberculosis Drug TMC207